Explanatory note on new interim order to advance COVID-19 clinical trials
IO No. 2 supports Canada’s continued focus on dealing with the significant risk that COVID-19 continues to pose to the health and safety of Canadians.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Explanatory note on new interim order to advance COVID-19 clinical trialsHTMLEnglish publication HTML
-
Explanatory note on new interim order to advance COVID-19 clinical trialsHTMLFrench publication HTML
Similar records